| scholarly article | Q13442814 |
| P2093 | author name string | O Haller | |
| M Bouloy | |||
| M Huerre | |||
| H Khun | |||
| J Pavlovic | |||
| C Janzen | |||
| P Vialat | |||
| P2860 | cites work | Functional role of type I and type II interferons in antiviral defense | Q24276429 |
| The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase | Q24561643 | ||
| Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity | Q24599944 | ||
| The carboxy-terminal acidic domain of Rift Valley Fever virus NSs protein is essential for the formation of filamentous structures but not for the nuclear localization of the protein. | Q27469709 | ||
| Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections | Q27469723 | ||
| Genetically determined, interferon-dependent resistance to influenza virus in mice | Q27485058 | ||
| How cells respond to interferons | Q27861006 | ||
| Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. | Q28609759 | ||
| Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems | Q29039793 | ||
| Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures | Q29618978 | ||
| Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein | Q33810694 | ||
| When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. | Q34380769 | ||
| Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene | Q35760833 | ||
| Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine | Q36131361 | ||
| Products of the porcine group C rotavirus NSP3 gene bind specifically to double-stranded RNA and inhibit activation of the interferon-induced protein kinase PKR. | Q36634265 | ||
| Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs | Q37095192 | ||
| The Rift Valley fever epizootic in Egypt 1977–1978 1. Description of the epizootic and virological studies | Q39240187 | ||
| The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice | Q39588385 | ||
| The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules | Q39870549 | ||
| An IkappaB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages | Q39877213 | ||
| The Rift Valley fever virus nonstructural protein NSs is phosphorylated at serine residues located in casein kinase II consensus motifs in the carboxy-terminus | Q40630761 | ||
| Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation | Q40642621 | ||
| Analysis of the 3' terminal sequence recognized by the Rift Valley fever virus transcription complex in its ambisense S segment | Q40656673 | ||
| Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. | Q40679919 | ||
| Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded human liver by immunohistochemical analysis | Q40743848 | ||
| Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian sandfly fever, and Uukuniemi viruses | Q40752380 | ||
| Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine | Q40759549 | ||
| Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon response | Q40768376 | ||
| Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha. | Q40775763 | ||
| Identification of mutations in the M RNA of a candidate vaccine strain of Rift Valley fever virus | Q40776401 | ||
| Viral determinants of virulence for Rift Valley fever (RVF) in rats | Q40782624 | ||
| Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator | Q40806370 | ||
| Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development | Q40814834 | ||
| JNK2 and IKKbeta are required for activating the innate response to viral infection | Q40907787 | ||
| Induction of virus-inhibiting factor or interferon in mice by strains with different virulence of Rift Valley fever virus | Q40919649 | ||
| The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha. | Q40944954 | ||
| Rift Valley Fever Virus Hepatitis: Light and Electron Microscopic Studies in the Mouse | Q40983070 | ||
| Inhibition of nuclear factor kappaB activation by a virus-encoded IkappaB-like protein | Q44642218 | ||
| In situ analysis of proteolipid protein gene transcripts during persistent Theiler's virus infection | Q45854023 | ||
| Immune response in mice that lack the interferon-gamma receptor | Q62022366 | ||
| A recombinant human interferon-alpha B/D hybrid with a broad host-range | Q70166751 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Rift Valley fever | Q326638 |
| Rift Valley fever virus | Q14276794 | ||
| Rift Valley fever phlebovirus | Q24809101 | ||
| P304 | page(s) | 1371-1377 | |
| P577 | publication date | 2001-02-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs | |
| P478 | volume | 75 |
| Q40325815 | A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge. |
| Q41898857 | A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferon-mediated signal transduction |
| Q33316823 | A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. |
| Q36747779 | A five-amino-acid deletion of the eastern equine encephalitis virus capsid protein attenuates replication in mammalian systems but not in mosquito cells |
| Q40186455 | A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep. |
| Q35027744 | A single vaccination with an improved nonspreading Rift Valley fever virus vaccine provides sterile immunity in lambs. |
| Q35616459 | A ΩXaV motif in the Rift Valley fever virus NSs protein is essential for degrading p62, forming nuclear filaments and virulence |
| Q35077969 | Advances in Rift Valley fever research: insights for disease prevention |
| Q37329569 | Akabane virus nonstructural protein NSm regulates viral growth and pathogenicity in a mouse model |
| Q33927167 | Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infection |
| Q42778332 | Alterations in the host transcriptome in vitro following Rift Valley fever virus infection |
| Q34031858 | Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice |
| Q34895197 | Antigenic drift, antigenic shift and interferon antagonists: how bunyaviruses counteract the immune system |
| Q37633698 | Antiviral autophagy restrictsRift Valley fever virus infection and is conserved from flies to mammals |
| Q35165344 | Association of symptoms and severity of rift valley fever with genetic polymorphisms in human innate immune pathways |
| Q37628197 | Attacked from All Sides: RNA Decay in Antiviral Defense |
| Q54217244 | Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates. |
| Q37509225 | Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR. |
| Q24289112 | Biological Transmission of Arboviruses: Reexamination of and New Insights into Components, Mechanisms, and Unique Traits as Well as Their Evolutionary Trends |
| Q35000433 | Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. |
| Q39776458 | Bunyamwera virus nonstructural protein NSs counteracts interferon regulatory factor 3-mediated induction of early cell death |
| Q38613824 | Bunyaviruses and the type I interferon system |
| Q59351865 | CD4 T cells, CD8 T cells, and monocytes coordinate to prevent Rift Valley fever virus encephalitis |
| Q40448667 | Characterization of Rift Valley fever virus transcriptional terminations. |
| Q37565486 | Characterization of a novel Negevirus and a novel Bunyavirus isolated from Culex (Culex) declarator mosquitoes in Trinidad |
| Q30671497 | Characterization of the Sandfly fever Naples species complex and description of a new Karimabad species complex (genus Phlebovirus, family Bunyaviridae). |
| Q27305612 | Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse |
| Q27477664 | Classical Swine Fever Virus Interferes with Cellular Antiviral Defense: Evidence for a Novel Function of Npro |
| Q40199478 | Comparative efficacy of two next-generation Rift Valley fever vaccines |
| Q33959989 | Comparative pathogenesis and systems biology for biodefense virus vaccine development |
| Q27330115 | Correlative Gene Expression to Protective Seroconversion in Rift Valley Fever Vaccinates |
| Q33705717 | Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSs |
| Q34262159 | Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging |
| Q35531617 | Creation of a nonspreading Rift Valley fever virus |
| Q38748778 | Creation of a recombinant Rift Valley fever virus with a two-segmented genome |
| Q24276409 | Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice |
| Q36286082 | Curcumin inhibits Rift Valley fever virus replication in human cells. |
| Q41929716 | Current Status of Rift Valley Fever Vaccine Development |
| Q36254960 | Cytokine response in mouse bone marrow derived macrophages after infection with pathogenic and non-pathogenic Rift Valley fever virus |
| Q35097798 | Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoes |
| Q35076889 | Design of chimeric alphaviruses with a programmed, attenuated, cell type-restricted phenotype |
| Q37321966 | Development of a RVFV ELISA that can distinguish infected from vaccinated animals |
| Q40123495 | Development of a sheep challenge model for Rift Valley fever. |
| Q36559849 | Dicer-2- and Piwi-mediated RNA interference in Rift Valley fever virus-infected mosquito cells |
| Q33443358 | Differential Antagonism of Human Innate Immune Responses by Tick-Borne Phlebovirus Nonstructural Proteins |
| Q40101969 | Discovery and characterisation of a new insect-specific bunyavirus from Culex mosquitoes captured in northern Australia |
| Q59355330 | Discovery and high prevalence of Phasi Charoen-like virus in field-captured Aedes aegypti in South China |
| Q37336396 | Discovery of a unique novel clade of mosquito-associated bunyaviruses |
| Q35107614 | Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR. |
| Q40292321 | Efficacy of three candidate Rift Valley fever vaccines in sheep. |
| Q33911860 | Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs. |
| Q39893246 | Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses |
| Q37093265 | Essential role of the NV protein of Novirhabdovirus for pathogenicity in rainbow trout. |
| Q27488281 | Establishment of a Bluetongue Virus Infection Model in Mice that Are Deficient in the Alpha/Beta Interferon Receptor |
| Q40198870 | Evaluation of nonspreading Rift Valley fever virus as a vaccine vector using influenza virus hemagglutinin as a model antigen. |
| Q38793701 | Evolution and Antiviral Specificities of Interferon-Induced Mx Proteins of Bats against Ebola, Influenza, and Other RNA Viruses. |
| Q35971398 | Exotic emerging viral diseases: progress and challenges |
| Q28208207 | Expression strategies of ambisense viruses |
| Q40170227 | Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination |
| Q40059072 | Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy |
| Q34429914 | Functional analysis of Rift Valley fever virus NSs encoding a partial truncation |
| Q44170263 | Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells |
| Q35192825 | Gouleako virus isolated from West African mosquitoes constitutes a proposed novel genus in the family Bunyaviridae |
| Q36177564 | Hantavirus regulation of type I interferon responses |
| Q57212939 | Heartland Virus Epidemiology, Vector Association, and Disease Potential |
| Q33439713 | Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies |
| Q38287391 | Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein. |
| Q33918307 | Host alternation is necessary to maintain the genome stability of rift valley fever virus |
| Q59356371 | Human immune cell engraftment does not alter development of severe acute Rift Valley fever in mice |
| Q28216424 | Identification of a novel RNA silencing suppressor, NSs protein of Tomato spotted wilt virus |
| Q39501528 | In Vivo Conditions Enable IFNAR-Independent Type I Interferon Production by Peritoneal CD11b+ Cells upon Thogoto Virus Infection |
| Q48236999 | In vitro and in vivo studies of the Interferon-alpha action on distinct Orthobunyavirus |
| Q35801885 | Induction of DNA damage signaling upon Rift Valley fever virus infection results in cell cycle arrest and increased viral replication |
| Q34260234 | Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection |
| Q33781480 | Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. |
| Q24302351 | Inhibition of Dugbe nairovirus replication by human MxA protein |
| Q40554311 | Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist |
| Q27470247 | Inhibition of Transcription and Translation in Sindbis Virus-Infected Cells |
| Q40044869 | Innate Immune Basis for Rift Valley Fever Susceptibility in Mouse Models. |
| Q37945237 | Innate antiviral response: role in HIV-1 infection |
| Q35562180 | Innate immune activation as a broad-spectrum biodefense strategy Prospects and research challenges |
| Q34251382 | Innate immune response to Rift Valley fever virus in goats |
| Q24670740 | Interaction of Bunyamwera Orthobunyavirus NSs protein with mediator protein MED8: a mechanism for inhibiting the interferon response |
| Q37332576 | Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis |
| Q38150059 | Interferon α/β receptor knockout mice as a model to study bluetongue virus infection |
| Q34660504 | Interferon, Mx, and viral countermeasures |
| Q33369068 | Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses |
| Q39043773 | Interferon-stimulated poly(ADP-Ribose) polymerases are potent inhibitors of cellular translation and virus replication |
| Q38376184 | Interplay between the Virus and Host in Rift Valley Fever Pathogenesis |
| Q45372924 | Interventions Against West Nile Virus, Rift Valley Fever Virus, and Crimean-Congo Hemorrhagic Fever Virus: Where Are We? |
| Q27480353 | La Crosse Bunyavirus Nonstructural Protein NSs Serves To Suppress the Type I Interferon System of Mammalian Hosts |
| Q33877293 | Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections |
| Q33442499 | Mapping of transcription termination within the S segment of SFTS phlebovirus facilitated the generation of NSs-deletant viruses |
| Q34669736 | Mechanisms of inhibition of the host interferon alpha/beta-mediated antiviral responses by viruses |
| Q30562554 | Metagenomic shotgun sequencing of a Bunyavirus in wild-caught Aedes aegypti from Thailand informs the evolutionary and genomic history of the Phleboviruses |
| Q36208133 | Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin |
| Q61803865 | Modeling Arboviral Infection in Mice Lacking the Interferon Alpha/Beta Receptor |
| Q36489477 | Modifying the NSs gene to improve live-attenuated vaccine for Rift Valley fever. |
| Q57017486 | Molecular Biology of Rift Valley Fever Virus~!2009-11-04~!2009-11-25~!2010-04-22~! |
| Q59351098 | Molecular aspects of Rift Valley fever virus and the emergence of reassortants |
| Q36652695 | Molecular biology and genetic diversity of Rift Valley fever virus |
| Q33886954 | Molecular biology of rift valley Fever virus |
| Q35751132 | Monitoring activation of the antiviral pattern recognition receptors RIG-I and PKR by limited protease digestion and native PAGE. |
| Q40083734 | Mouse model for the Rift Valley fever virus MP12 strain infection. |
| Q37049951 | Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression. |
| Q38774860 | NSs Virulence Factor of Rift Valley Fever Virus Engages the F-Box Proteins FBXW11 and β-TRCP1 To Degrade the Antiviral Protein Kinase PKR |
| Q96952294 | NSs amyloid formation is associated with the virulence of Rift Valley fever virus in mice |
| Q39960501 | NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription |
| Q39195523 | NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase |
| Q39547955 | NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62. |
| Q36353971 | No Evidence of Gouléako and Herbert Virus Infections in Pigs, Côte d'Ivoire and Ghana |
| Q38150190 | Non-structural proteins of arthropod-borne bunyaviruses: roles and functions |
| Q40130716 | Nonspreading Rift Valley Fever Virus Infection of Human Dendritic Cells Results in Downregulation of CD83 and Full Maturation of Bystander Cells. |
| Q27027003 | Novel approaches to develop Rift Valley fever vaccines |
| Q27473101 | Novel gene product of Thogoto virus segment 6 codes for an interferon antagonist |
| Q37252699 | Nuclear relocalization of polyadenylate binding protein during rift valley fever virus infection involves expression of the NSs gene |
| Q43167772 | Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach. |
| Q59350395 | Pathogenesis of Rift Valley Fever Virus Aerosol Infection in Knockout Hamsters |
| Q44169686 | Peripheral blood biomarkers of disease outcome in a monkey model of Rift Valley Fever encephalitis |
| Q34464155 | Persistent Sin Nombre virus infection in the deer mouse (Peromyscus maniculatus) model: sites of replication and strand-specific expression |
| Q26747457 | Phleboviruses and the Type I Interferon Response |
| Q48097495 | Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection |
| Q91675188 | Polyamine Depletion Inhibits Bunyavirus Infection via Generation of Noninfectious Interfering Virions |
| Q40365121 | Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(-/-) mice induced by different DNA vaccination regimens. |
| Q35912398 | Protein Kinase R Degradation Is Essential for Rift Valley Fever Virus Infection and Is Regulated by SKP1-CUL1-F-box (SCF)FBXW11-NSs E3 Ligase |
| Q37439419 | Punta Toro virus (Bunyaviridae, Phlebovirus) infection in mice: strain differences in pathogenesis and host interferon response |
| Q38217394 | RIG-I-like receptors and negative-strand RNA viruses: RLRly bird catches some worms |
| Q36759999 | RNA helicase signaling is critical for type i interferon production and protection against Rift Valley fever virus during mucosal challenge |
| Q35802862 | Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic |
| Q40311587 | Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene |
| Q38614407 | Restriction of rift valley Fever virus virulence in mosquito cells |
| Q33570326 | Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines |
| Q33745109 | Reverse-phase phosphoproteome analysis of signaling pathways induced by Rift valley fever virus in human small airway epithelial cells |
| Q42553036 | Rift Valley Fever Vaccine Development, Progress and Constraints |
| Q35975309 | Rift Valley Fever Vaccine Virus Clone 13 Is Able to Cross the Ovine Placental Barrier Associated with Foetal Infections, Malformations, and Stillbirths |
| Q34475358 | Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments. |
| Q40038707 | Rift Valley fever phlebovirus NSs protein core domain structure suggests molecular basis for nuclear filaments |
| Q37006803 | Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice |
| Q40499504 | Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment |
| Q26745530 | Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins |
| Q33406230 | Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation |
| Q36827204 | Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses |
| Q40308414 | Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection. |
| Q36397378 | Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis |
| Q40237478 | Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep. |
| Q92802082 | Rift Valley fever virus targets the maternal-foetal interface in ovine and human placentas |
| Q90093666 | Rift Valley fever virus vaccination induces long-lived, antigen-specific human T cell responses |
| Q34221766 | Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep |
| Q26795706 | Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe |
| Q28539632 | Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model |
| Q37393780 | Rift valley fever vaccines |
| Q36484009 | Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals |
| Q33755025 | Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system |
| Q34174444 | Rift valley fever: recent insights into pathogenesis and prevention |
| Q39789324 | Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins |
| Q34355773 | Roles of nonstructural protein nsP2 and Alpha/Beta interferons in determining the outcome of Sindbis virus infection |
| Q54247042 | SFTS phlebovirus promotes LC3-II accumulation and nonstructural protein of SFTS phlebovirus co-localizes with autophagy proteins. |
| Q28066283 | Safety and Efficacy Profile of Commercial Veterinary Vaccines against Rift Valley Fever: A Review Study |
| Q90912985 | Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats |
| Q40322035 | Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves |
| Q36501630 | Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep. |
| Q52395358 | Schmallenberg virus non-structural protein NSm: Intracellular distribution and role of non-hydrophobic domains. |
| Q34550761 | Schmallenberg virus pathogenesis, tropism and interaction with the innate immune system of the host. |
| Q36127490 | Serum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe disease |
| Q35036515 | Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation |
| Q40008303 | Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells |
| Q33415380 | Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis |
| Q37433779 | Short Interfering RNA Inhibits Rift Valley Fever Virus Replication and Degradation of Protein Kinase R in Human Cells |
| Q40274399 | Sindbis virus nonstructural protein nsP2 is cytotoxic and inhibits cellular transcription |
| Q36109044 | Single-Molecule FISH Reveals Non-selective Packaging of Rift Valley Fever Virus Genome Segments |
| Q36326847 | Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates |
| Q35868079 | Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge |
| Q39734555 | Species-independent bioassay for sensitive quantification of antiviral type I interferons |
| Q38152910 | Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: hide, mask, hit. |
| Q33198557 | TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. |
| Q92857639 | The Antiviral and Antitumor Effects of Defective Interfering Particles/Genomes and Their Mechanisms |
| Q35105093 | The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. |
| Q36694012 | The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype |
| Q36442330 | The Non-structural Protein of Crimean-Congo Hemorrhagic Fever Virus Disrupts the Mitochondrial Membrane Potential and Induces Apoptosis |
| Q40208169 | The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff |
| Q34354086 | The Rift Valley Fever virus protein NSm and putative cellular protein interactions |
| Q27478045 | The S Segment of Punta Toro Virus (Bunyaviridae, Phlebovirus) Is a Major Determinant of Lethality in the Syrian Hamster and Codes for a Type I Interferon Antagonist |
| Q89879735 | The Utility of Human Immune System Mice for High-Containment Viral Hemorrhagic Fever Research |
| Q36155392 | The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine |
| Q40174551 | The genetic basis for susceptibility to Rift Valley fever disease in MBT/Pas mice |
| Q36346824 | The interferon response circuit: induction and suppression by pathogenic viruses |
| Q38170306 | The molecular biology of nairoviruses, an emerging group of tick-borne arboviruses |
| Q34191969 | The pathogenesis of Rift Valley fever |
| Q31034150 | The role of interferon antagonist, non-structural proteins in the pathogenesis and emergence of arboviruses |
| Q34399316 | The use of Nanotrap particles for biodefense and emerging infectious disease diagnostics |
| Q34097995 | Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice. |
| Q45421156 | Tomato spotted wilt virus particle assembly and the prospects of fluorescence microscopy to study protein-protein interactions involved |
| Q35841573 | Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy |
| Q36750723 | Viral suppression of the interferon system |
| Q38326807 | Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH |
| Q35027514 | Viruses and the type I interferon antiviral system: induction and evasion |
| Q26823495 | Viruses of the family Bunyaviridae: are all available isolates reassortants? |
| Q97519293 | eIF2B as a Target for Viral Evasion of PKR-Mediated Translation Inhibition |
| Q24319790 | p53 Activation following Rift Valley fever virus infection contributes to cell death and viral production |
Search more.